is glp -1 safe GLP-1 Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity Semaglutide GLP-1 Medical Weight Loss

Maintaining Results After GLP-1 Treatment The journey doesnt end when your GLP-1 treatment concludes in fact, what you do next determines your long-term success with maintaining weight loss results

FDA decision could be as early as 2027 based on estimated trial completion dates

Stopping GLP-1 therapy tends to bring appetite back, and weight regain is documented and common when treatment ends without a maintenance plan in place

This shift recognizes both the benefits of these medications and the importance of patient-specific decision making, These precautions may include a clear liquid diet for 24 hours before surgery or closer monitoring during anesthesia

Semaglutide is available in two forms: a once-weekly subcutaneous injection (Ozempic for diabetes, Wegovy for weight management) and a once-daily oral tablet (Rybelsus for diabetes)

Multi-Target Synergistic Effects GLP-1 receptors (GLP-1R) play a key role in regulating glucose balance, fat metabolism, and food intake